Sort
39,280 grants matching “leukemia”
Biochemistry And Pharmacology of Fluorinated Imidazoles
$313,867Kenneth L Kirk · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
MOLECULAR MECHANISMS OF ARA-C THERAPY IN MAN
$313,829Dana-Farber Cancer Institute · R01 · FY2001 · CA
Pediatric Cancer, Family Conflict and Child Adjustment
$313,829Lynn Fainsilber Katz · University Of Washington · R01 · FY2013 · CA
Combining Virotherapy and Immunotherapy for Cancer
$313,821University Of California Los Angeles · R01 · FY2004 · CA
Genetic Determinants-JC Virus Replication/Pathogenicity
$313,803University Of Hawaii At Manoa · S11 · FY2001 · NS
FANCONI ANEMIA GENE FUNCTION IN GENOME STABILITY AND TUMOR SUPPRESSION
$313,757Oregon Health And Science University · P01 · FY2005 · HL
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$313,752Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2016 · CA
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
$313,740Wenyong Chen · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
$313,740Wenyong Chen · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
$313,740Wenyong Chen · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunity
$313,726Luc Van Kaer · Vanderbilt University · R01 · FY2015 · DK
DLI using genetically modified T cells: Phase 1 trial
$313,650Washington University · R21 · FY2004 · CA
DLI using genetically modified T cells: Phase 1 trial
$313,650Washington University · R21 · FY2005 · CA
A Suite of Tumor Targeting Peptides for Personalized Therapy of Lung Cancer
$313,615Kathlynn C Brown · Ut Southwestern Medical Center · R01 · FY2012 · CA
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
$313,613Carlo M Croce · Ohio State University · R01 · FY2010 · CA
Regulation of HTLV-I replication by the viral p30
$313,611Christophe P Nicot · University Of Kansas Medical Center · R01 · FY2007 · AI
The Dichotomy of Alk1 and Alk5 Signaling Pathways in Vascular Response to Injury
$313,587Zhihua Jiang · University Of Florida · R01 · FY2015 · HL
Combination Gene Therapy and Th1Th2 Therapy
$313,579Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Understanding T Cell Rapamycin Resistance
$313,579Daniel Fowler · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Promotion of PDT Induced phototoxicity by bile acids
$313,574Wayne State University · R01 · FY2002 · CA
Structure and Mechanism in Intracellular Notch Signaling
$313,549Douglas E Barrick · Johns Hopkins University · R01 · FY2014 · GM
Role of the BCR in B Cell Chronic Lymphocytic Leukemia
$313,533Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2010 · CA
Role of the BCR in B Cell Chronic Lymphocytic Leukemia
$313,533Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2009 · CA
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
$313,503Britta Will · Albert Einstein College Of Medicine · R01 · FY2018 · CA
Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL
$313,489Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2016 · CA